Full Press Release Details
All Primers Perspectives Progress Press Third Quarter 2025 Financials & Operational Update Date published: November 12, 2025 3:09 pm PST Share Related Documents: Conference Call Conference Call Transcript News Release
SKYE Neutral Sentiment
Third Quarter 2025 Financials & Operational Update
Key Takeaway: The article provides a brief update on the financial and operational status of SKYE for the third quarter of 2025. It mentions the publication date and includes references to a conference call and related documents. However, it lacks detailed financial data or operational insights.
Price reaction · baseline $1.58 (2025-11-12T15:08:00.000Z) · hit during market hours · clean, no other SKYE news in the window
day 0 close · peak
-3.8%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+84%
120-day peak, hindsight
Typical move
24.3%
average across 4 past catalysts
Cash runway
~4 mo
High dilution risk
Lead asset
Nimacimab
Phase 2 · Obesity